Andrew Hykes
CIK 1806431 · President and CEO · last filed 2025-02-19
Andrew Hykes is a President and CEO who has filed 64 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for NARI, was dated Feb 19, 2025. Across all open-market trades the lifetime net is −$34.1M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
64
-$34.09M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Inari Medical, Inc. (NARI) Delisted | President and CEO | 0 | $79.97 | $0 | -$34.09M | 64 | 2025-02-19 |
Recent Filings
64 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-19 | Inari Medical, Inc. (NARI) Delisted | Mixed | −702,894 | $0 | EDGAR |
| 2025-02-12 | Inari Medical, Inc. (NARI) Delisted | Exer (M) | +194,538 | $184.6K | EDGAR |
| 2025-02-06 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +67,282 | $0 | EDGAR |
| 2025-01-03 | Inari Medical, Inc. (NARI) Delisted | Tax (F) | −4,409 | -$225.1K | EDGAR |
| 2024-12-20 | Inari Medical, Inc. (NARI) Delisted | Sell (S) | −3,000 | -$165.9K | EDGAR |
| 2024-11-22 | Inari Medical, Inc. (NARI) Delisted | Sell (S) | −3,000 | -$152.5K | EDGAR |
| 2024-10-31 | Inari Medical, Inc. (NARI) Delisted | Sell (S) | −3,000 | -$150.0K | EDGAR |
| 2024-10-03 | Inari Medical, Inc. (NARI) Delisted | Tax (F) | −4,222 | -$171.5K | EDGAR |
| 2024-08-22 | Inari Medical, Inc. (NARI) Delisted | Sell (S) | −3,000 | -$150.0K | EDGAR |
| 2024-07-24 | Inari Medical, Inc. (NARI) Delisted | Sell (S) | −3,000 | -$165.7K | EDGAR |